A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

270

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

August 7, 2026

Study Completion Date

March 10, 2027

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG

GZR18

Administered SC

DRUG

Placebo

Administered SC